Development of the novel formulations of perospirone for the treatment of schizophrenia.
Zhang Z, Ke F, Wu J, Li X, Chen X, Zhang L, Jing P, Liu Z, Liu Z, Lu R, Fu S, Zhou M, Lin Y, Sun X, Zhong Z.
Zhang Z, et al. Among authors: fu s.
Drug Deliv Transl Res. 2024 Oct 31. doi: 10.1007/s13346-024-01730-7. Online ahead of print.
Drug Deliv Transl Res. 2024.
PMID: 39480624